Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.

作者: George J. Despotis , Jr Hogue , Sam A. Santoro , J. Heinrich Joist , Patrick W. MT Barnes

DOI: 10.1097/00003246-199510000-00011

关键词:

摘要: Objectives : To evaluate the responsiveness of whole blood activated partial thromboplastin time (aPTT) to varying heparin doses in vitro and examine ex vivo relationship aPTT plasma concentration. Design Prospective, controlled laboratory study. Setting Surgical suites at a tertiary center. Patients patients volunteers center were eligible for inclusion this In evaluation was performed using specimens obtained from each five, healthy volunteers. Ex 30 cardiac surgical before after systemic administration extracorporeal circulation. Interventions Blood added syringes containing amounts unfractionated porcine evaluation. For evaluation, 20 U/kg heparin. Measurements Main Results divided into two aliquots mixing with One aliquot used measure coagulation monitor immediately collection 3 mins later, second determine conventional, laboratory-based assay. Linear regression analysis demonstrated high correlation (r = .94 ; r2 =.88) between assay systems bias mean measurement difference 1.6 secs ± 2 sD limits -15 + 18.2 secs. As indicated by comparable slopes, increasing concentration similar among individual subjects. Whole measurements specimen storage immediate measurements. aliquots. duplicate an anti-factor X active chromogenic A =.89 r =.79) observed. Conclusions Heparin aPTT, measured portable monitor, is that conventional over clinically relevant range concentrations vivo. On-site should be useful clinical situations requiring rapid results.

参考文章(36)
Blood conservation--a critical care imperative. Critical Care Medicine. ,vol. 19, pp. 313- 314 ,(1991) , 10.1097/00003246-199103000-00001
Triplett Da, Banez Ei, Koepke J, Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time. American Journal of Clinical Pathology. ,vol. 74, pp. 569- ,(1980)
High Ka, Murray Bf, Rose Vl, Dermott Sc, McIver Mm, Oberhardt Bj, Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. Archives of Pathology & Laboratory Medicine. ,vol. 117, pp. 611- 617 ,(1993)
J. Hirsh, Drug therapy : heparin The New England Journal of Medicine. ,vol. 324, pp. 1565- 1574 ,(1991)
Powers Peterson, Eugene L Gottfried, The Effects of Inaccurate Blood Sample Volume on Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) Thrombosis and Haemostasis. ,vol. 47, pp. 101- 103 ,(1982) , 10.1055/S-0038-1657138
T W Barrowcliffe, Elaine Gray, Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin. Thrombosis and Haemostasis. ,vol. 46, pp. 634- 637 ,(1981) , 10.1055/S-0038-1653435
J T Brandt, D A Triplett, Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time. American Journal of Clinical Pathology. ,vol. 76, pp. 530- 537 ,(1981)
G.J. Despotis, S.A. Santoro, E. Spitznagel, K.M. Kater, J.L. Cox, P. Barnes, D.G. Lappas, Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 107, pp. 271- 279 ,(1994) , 10.1016/S0022-5223(94)70481-3
A D Heyns, D J van den Berg, P H Kleynhans, P W du Toit, Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time. Journal of Clinical Pathology. ,vol. 34, pp. 63- 68 ,(1981) , 10.1136/JCP.34.1.63
JOHN OWEN, Erroneous Activated Partial Thromboplastin Time Annals of Internal Medicine. ,vol. 89, pp. 146- 147 ,(1978) , 10.7326/0003-4819-89-1-146_2